Thomas Gabrielczyk

Thomas Gabrielczyk's articles

Calluna Pharma starts efficacy test with unique IPF antibody
  1. Biotechnology

Calluna Pharma starts efficacy test with unique IPF antibody

Among the 110 drug development programmes currently underway worldwide targeting the US$4.5bn IPF market,  Calluna Pharma‘s IgG1 antibody directed against the damage-associated molecular pattern (DAMP) protein S100A4 stands out for its unique mechanism of action. Preclinical studies demonstrated selective inhibition of both fibroblast activation and pro-fibrotic inflammation, alongside a favourable safety and immunogenicity profile, which […]
Written by
Dewpoint Tx' current pipeline
  1. Biotechnology

Dewpoint Therapeutics cuts workforce, refocuses pipeline

Despite securing US$287m from 16 investors across three funding rounds—US$60m (Series A, 2019), US$77m (Series B, 2020), and US$150m (Series C, 2022)—the firm cited a high burn rate as the reason for scaling back. Dewpoint will now prioritise clinical development of its lead candidate, DPTx3186, a beta-catenin inhibitor targeting the WNT signalling pathway, in gastric […]
Written by
UK Food Standards Agency accepts Gourmey’s application for cultivated Foie Gras
  1. Biotechnology

UK Food Standards Agency accepts Gourmey’s application for cultivated Foie Gras

The acceptance by the UK marks a new phase in what is emerging as a closely observed regulatory race. With similar food safety requirements across the EU, the US, Singapore, Switzerland and the UK, the process will provide insights into which regulatory frameworks are most efficient in assessing and approving novel food technologies. Earlier this […]
Written by
EU Commissioner Várhelyi revives Biotech Act for 2025
  1. Biotechnology

EU Commissioner Várhelyi revives Biotech Act for 2025

In a panel discussion at Medicines for Europe Annual Conference, EU Health Commissioner Olivér Várhelyi made a surprise announcement that the Commission will adopt the EU Biotech Act by the end of this year, citing growing “global challenges”. According to the EU Commission’s work programme, the legislation was initially scheduled for adoption in Q3 2025, […]
Written by
GEA to open food biotech pilot-scale facility in USA
  1. Biotechnology

GEA to open food biotech pilot-scale facility in USA

Similar to GEA’s initial scaling facility for cell-based food production in Germany, the recently opened 10,000-square-metre facility in Janesville, Wisconsin is intended to assist scientists and entrepreneurs in the developing food technology sector to increase their production to industrial levels. With a 40% market share and a thriving start-up scene, the US is ahead of […]
Written by
EU set to improve investment for biotech start-ups and scale-ups
  1. Biotechnology

EU set to improve investment for biotech start-ups and scale-ups

The European Commission has unveiled a new strategy entitled ‘Choose Europe to start and scale’, which aims to strengthen the development and financing of start-ups and scale-ups within the European Union, particularly in innovation-driven sectors such as biotechnology, quantum computing and deep tech. The strategy, published on 28 May 2025, addresses the challenges faced by […]
Written by
Countdown to SLAS Europe: NestEgg Labs BV
  1. Biotechnology

Countdown to SLAS Europe: NestEgg Labs BV

Founded in 2022 by Tanner Carden (CEO) and Hans Keijdener, Maastricht-based start-up NestEgg Labs BV focuses on developing interoperable automation systems for cell culture that reduce manual intervention, improve workflow reproducibility, and limit plastics waste. At the core of NestEgg’s offering is Ovation, a smart incubator platform designed to automate key stages of the cell […]
Written by
Countdown to SLAS Europe: Minos Biosciences SAS
  1. Biotechnology

Countdown to SLAS Europe: Minos Biosciences SAS

Paris-based Minos Biosciences SAS’ (www.minos.bio) mission is to improve the understanding and treatment of complex diseases such as cancer, infectious and autoimmune diseases. As AI-powered drug discovery and therapeutic innovation holds great promise, the company’s MinoSuiteTM integrated cell analysis platform creates unprecedented multimodal datasets that will offer direct, ground-truth labels for AI training, opening  up […]
Written by
US President depriorises biotechnology - European Biotechnology Magazine
  1. Biotechnology

US President depriorises biotechnology – European Biotechnology Magazine

The order was published and executed to advance engineering biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security. President Trump’s U-turn on biotechnology could soon turn out to be an own goal. The Republican senators from five federal states – Nebraska, Indiana, […]
Written by
BRAIN Biotech partners with PX Group in microbial gold recycling
  1. Biotechnology

BRAIN Biotech partners with PX Group in microbial gold recycling

Industrial biotech specialist BRAIN Biotech and PX Group have extended its collaboration in highly effective microbial gold recovery from e-waste. Back in 2017, BRAIN Biotech developed a container-based mobile pilot plant for the bioleaching of metals dubbed BioXtractor. An advanced version called BioXtractor V2 was financed by PX Group and is now jointly owned by […]
Written by
SLAS: automation start ups set to enable P4 medicine
  1. Biotechnology

SLAS: automation start ups set to enable P4 medicine

Leroy Hood’s vision of P4 or ‘systemic’ medicine (preventive, predictive, personalised, participatory) is becoming a reality. By using omics data and medical records to create AI-powered individual health profiles, new automated product innovations aim to target diseases before symptoms even appear, reducing healthcare costs. On the second day of the SLAS 2025 conference, SLAS Ignite […]
Written by

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.